The Business Case for Preventing Ventilator-Associated Pneumonia in Pediatric Intensive Care Unit Patients
- 1 November 2008
- journal article
- Published by Elsevier BV in The Joint Commission Journal on Quality and Patient Safety
- Vol. 34 (11), 629-638
- https://doi.org/10.1016/s1553-7250(08)34080-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- PEDIATRIC VAP BUNDLE REDUCES VAP IN PICU, NICU, CICU.Critical Care Medicine, 2006
- The Cost-Shift Payment ‘Hydraulic’: Foundation, History, And ImplicationsHealth Affairs, 2006
- Impact of Ventilator-Associated Pneumonia on Resource Utilization and Patient OutcomeInfection Control & Hospital Epidemiology, 2004
- Oral decontamination is cost-saving in the prevention of ventilator-associated pneumonia in intensive care unitsCritical Care Medicine, 2004
- Implementation of an institutional program to improve clinical and financial outcomes of mechanically ventilated patients: One-year outcomes and lessons learned*Critical Care Medicine, 2003
- Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center*Critical Care Medicine, 2003
- Feeding Back Surveillance Data To Prevent Hospital-Acquired InfectionsEmerging Infectious Diseases, 2001
- Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unitEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Nosocomial infection rates in adult and pediatric intensive care units in the United StatesAmerican Journal Of Medicine, 1991
- The Use of Preventable Adverse Outcomes to Study the Quality of Child Health Care A New Application of Case-Control ResearchMedical Care, 1984